• Printer Friendly Version
  • Decrease Text Size
  • Increase Text Size
  • PDF
Thursday, April 20, 2017

The Center for Breast Health at Good Samaritan Hospital Introduces 3D Mammography

3D Mammography exams are clinically proven to increase invasive cancer detection and reduce recall rates

news item

SUFFERN, N.Y. (October 20, 2016) -- The Center for Breast Health at Good Samaritan Hospital is now offering Genius™ 3D MAMMOGRAPHY™ exams. Utilizing advanced breast tomosynthesis technology, 3D exams are clinically proven to significantlyincrease the detection of breast cancers, while simultaneously decreasing the number ofwomen asked to return for additional testing.

“The system allows our radiologists to more effectively pinpoint the size, shape andlocation of abnormalities,” said Robert Yates, system director, Imaging Services.

In conventional 2D mammography, overlapping dense breast tissue is a common reason why  breast cancers may be missed and normal tissue may appear abnormal, leading to unnecessary callbacks. This exam includes a three-dimensional method of imaging that can greatly reduce the tissue overlap effect.

This technology is considered superior to conventional digital mammography and isapproved by the FDA. The new system is recommended for women of all ages and breast densities.

“If your insurance covers it, or if you are otherwise able to afford it, I would recommend getting a 3D mammogram, especially if you have dense breast tissue,” said Karen Karsif, M.D., medical director of The Center for Breast Health at Good Samaritan Hospital.

Large clinical studies in the U.S. and Europe have demonstrated the positive benefits of a Genius 3D MAMMOGRAPHY™ exam. The largest study to date on breast cancerscreening using the Genius exam was published in the June 25, 2014 issue of theJournal of the American Medical Association (JAMA). Findings include

·         A 41% increase in the detection of invasive breast cancers.

·         A 29% increase in the detection of all breast cancers.

·         A 15% decrease in women recalled for additional imaging.

“We are committed to the fight against breast cancer,” said Steven Reichard, D.O., a radiologist and director of women’s imaging. “In offering 3D mammograms, we canprovide a more accurate tool for breast cancer screening and therefore the best possible care for our patients.”

To schedule a 3D mammography, or if you have questions about this breasthealth procedure, please call 1-866-596-8456

About Good Samaritan Hospital, a Member of the Westchester Medical Center Health Network

Good Samaritan Hospital in Suffern, New York, is a 286-bed hospital providing emergency, medical, surgical, obstetrical/gynecological and acute care services to residents of Rockland and southern Orange Counties in New York; and northern Bergen County, New Jersey.  The hospital is home to a recognized cardiovascular program, comprehensive cancer treatment services, the area’s leading Wound and Hyperbaric Institute and outstanding maternal/child services that includes a Children’s Diagnostic Center. Good Samaritan Hospital also provides social, psychiatric and substance abuse services and its certified home care agency supports residents of the Hudson Valley and beyond.  For more information about Good Samaritan Hospital visitbschs.bonsecours.com or follow the hospital at Facebook.com/BSCGSRMC orTwitter.com/BSCHS

The new 3D Mammography machine at The Center for Breast Health at Good Samaritan Hospital with techs Larisa Kagan and Susan Foti.

Cutting the ribbon for  the new 3D Mammography machine at The Center for Breast Health at Good Samaritan Hospital are (l-r): Steven Reichard, D.O., director of women’s imaging, Kathy Medici, GSH Foundation board member, Mary Leahy, M.D., CEO, Bon Secours Charity Health System, Karen Karsif, M.D., medical director of The Center for Breast Health, Harold Peterson, GSH Foundation board chairman,  State Sen. David Carlucci, Robert Yates, system director, Imaging Services, and Myrnia Bass-Hargrove, director of community relations for Rockland County Executive Ed Day.